Olaratumab for Sarcoma Under Review After Negative Trial Olaratumab for Sarcoma Under Review After Negative Trial
The product has been used in combination with doxorubicin in patients with soft tissue sarcoma, but negative results from a confirmatory trial put its future in question.International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 1, 2019 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
WATCH: What is Ewing sarcoma?
Ewing sarcoma is a rare type of cancer occurring in the bones or in the soft tissue around the bones. (Source: ABC News: Health)
Source: ABC News: Health - January 27, 2019 Category: Consumer Health News Tags: Health Source Type: news
After winning accelerated approval, Lilly ’s cancer drug fails in study
An Eli Lilly treatment for advanced soft-tissue sarcoma missed the mark in a phase 3 study and will no longer be prescribed. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - January 21, 2019 Category: Pharmaceuticals Source Type: news
Lartruvo Fails in Confirmatory Sarcoma Trial
(MedPage Today) -- Lilly suspending promotion; could drug be pulled from U.S. market? (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - January 18, 2019 Category: American Health Source Type: news
Lilly Reports Results of Phase 3 Soft Tissue Sarcoma Study of LARTRUVO(R)
Study did not meet the primary endpoints of overall survival (OS) in the full study population or in the leiomyosarcoma (LMS) sub-population; there was no difference in survival between the study arms for either population.
There were no new safety sign... Biopharmaceuticals, Oncology Eli Lilly, LARTRUVO, olaratumab, soft tissue sarcoma, leiomyosarcoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 18, 2019 Category: Pharmaceuticals Source Type: news
High-Dose Chemo and Stem-Cell Rescue for Ewing Sarcoma High-Dose Chemo and Stem-Cell Rescue for Ewing Sarcoma
Consolidation high-dose chemotherapy with busulfan and melphalan may better survival in patients with Ewing sarcoma at high risk for relapse.Journal of Clinical Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 11, 2019 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
Opportunities in precision oncology and genomic profiling services in Asia Pacific
Launched in 2010 with a $25 million Series A financing led by Third Rock Ventures, Foundation Medicine released its first commercial assay called FoundationOne in 2012. The company develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumours, hematologic malignancies, and sarcomas. In December 2017, the company ’s assay FoundationOne CDx received approval from the US Food and Drug Administration (FDA). (Source: mobihealthnews)
Source: mobihealthnews - January 11, 2019 Category: Information Technology Source Type: news
New insights into a rare type of cancer open novel avenues of study
(Karolinska Institutet) Undifferentiated uterine sarcoma is a very rare but extremely aggressive cancer type. It can be divided into four groups with different characteristics of clinical importance -- a new study at Karolinska Institutet in Sweden reveals. The results, published in the journal Clinical Cancer Research, also show that the survival rate of patients with a certain type of tumour is better than predicted. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 8, 2019 Category: Cancer & Oncology Source Type: news
Rufus Wainwright: 2018 WebMD Health Hero, Ambassador
After losing their mother to clear cell sarcoma, the singer-songwriter and his sister wanted to honor her. Learn more about the foundation, which sponsors research into this rare type of cancer, and the woman who inspired it. (Source: WebMD Health)
Source: WebMD Health - January 2, 2019 Category: Consumer Health News Source Type: news
Woman's face was rebuilt using her shoulder bone and back muscle
Jen Taylor, 30, from London, needed seven months of chemotherapy before a life-changing operation to treat sarcoma with which she was diagnosed in August 2017 after noticing a lump. (Source: the Mail online | Health)
Source: the Mail online | Health - December 29, 2018 Category: Consumer Health News Source Type: news
Skin Cancer | Medscape Skin Cancer | Medscape
Nonmelanoma skin cancer primarily comprises basal cell carcinoma and squamous cell carcinoma. Other, rarer types of nonmelanoma skin cancer include dermatofibrosarcoma protuberans, Merkel cell carcinoma, and Kaposi ' s sarcoma. (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 28, 2018 Category: Consumer Health News Tags: Resource Center Source Type: news
Desmoid Tumors: Treatment Breakthrough With Sorafenib Desmoid Tumors: Treatment Breakthrough With Sorafenib
Desmoid tumors, a rare form of sarcoma, may finally have a standard of care after a National Cancer Institute trial showed that sorafenib was able to reduce progression rates by more than 85%.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 19, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
5 Things to Know About Sarcoma 5 Things to Know About Sarcoma
Although advances in treating sarcoma have historically been slow, new emerging therapies in the field of oncology are changing the way oncologists look at sarcoma.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 19, 2018 Category: Consumer Health News Tags: Hematology-Oncology Article Source Type: news
Uncovering a key mechanism in assembly of Avian Sarcoma Virus, a relative of HIV-1
(University of Alabama at Birmingham) Researchers used NMR to detail how the matrix domain of the Avian Sarcoma Virus Gag protein binds to certain phospholipids. These phospholipids are vital for Gag protein binding to the plasma membrane of a cell, as the virus replicates and takes its first step toward virus formation and budding. ASV is widely used as a model to study mechanisms of HIV infection and replication. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 18, 2018 Category: Infectious Diseases Source Type: news
